| Autor: |
Smith, Catherine H, Yiu, Zenas Z N, Bale, Tracy, Burden, A David, Coates, Laura C, Eckert, Elizabeth, Longley, Nicky, Mahil, Satveer K, McGuire, Arlene, Murphy, Ruth, Nelson-Piercy, Catherine, Owen, Caroline M, Parslew, Richard, Woolf, Richard T, Kiaee, Zahra Mansour, Constantin, Alina M, Ezejimofor, Martinsixtus C, Exton, Lesley S, Mustapa, M Firouz Mohd |
| Předmět: |
|
| Zdroj: |
British Journal of Dermatology; Feb2024, Vol. 190 Issue 2, p270-272, 3p |
| Abstrakt: |
The British Association of Dermatologists (BAD) has updated its clinical guideline for biologic therapy for psoriasis, including new treatments approved since the previous version. The guideline will now be a living guideline, updated as new evidence emerges. The decision aid for clinicians and patients has also been updated. The document provides information on different biologic treatments for psoriatic arthritis, including medication details, dosing frequency, approval dates, success rates, and potential side effects. It emphasizes that some treatments are recommended only after other options have failed and not all treatments are approved for psoriatic arthritis. The document is based on real-world data and aims to support clinical practice. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
